首页> 外文期刊>Retina >Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy
【24h】

Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy

机译:内透热加光凝治疗玻璃体切除术后继发巩膜切开部位血管化,以治疗糖尿病性视网膜病变

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the results of surgery with pars plana vitrectomy (PPV), endodiathermy of sclerotomy site fibrovascularization and adjuvant photocoagulation of the peripheral retina to the pars plana as treatment of recurrent vitreous hemorrhage secondary to PPV for proliferative diabetic retinopathy (PDR). METHODS: Tertiary care center, Barraquer Center of Ophthalmology, Barcelona, Spain. Prospective interventional study of 14 eyes of 14 consecutive patients aged 20 years to 47 years with recurrent vitreous hemorrhage because of sclerotomy site neovascularization secondary to PPV for PDR. All patients were treated by cataract, or transparent lens, extraction with intraocular lens implantation plus 20-gauge PPV of the vitreous base, including incarcerated vitreous of the sclerotomy site, together with endodiathermy of sclerotomy site fibrovascular tissue and adjuvant photocoagulation to the pars plana. Preoperative evaluation was performed by 20-MHz, high-resolution, anterior-segment ultrasonography of the neovascularized sclerotomy sites, pre- and postoperative visual acuity (logarithm of the minimum angle of resolution), and postoperative rebleeding rates. RESULTS: Recurrent vitreous hemorrhage appeared 8 ± 4 months after the initial PPV for PDR. Ten (71%) patients had isolated vascularization of a single sclerotomy site and 4 (29%) had vascularization of 2 sclerotomy sites. Nine of the 18 vascularized sites (50%) corresponded to optical fiber sclerotomies, 7 (39%) to vitreotome, and 2 (11%) to infusion sclerotomies. All the neovascularized sclerotomies presented sentinel vessels in the anterior segment. No patient showed postoperative recurrent vitreous hemorrhage during follow-up of 23 ± 10 months; all showed improved visual acuity, from initial 2.23 (±1.13 standard deviation) to final 0.23 (±0.09 standard deviation). CONCLUSION: According to our study, the technique of choice for the treatment of recurrent vitreous hemorrhage secondary to PPV for PDR is endodiathermy of sclerotomy site fibrovascularization and adjuvant photocoagulation of the peripheral retina to the pars plana. This technique treats the etiology of the problem, improves final best-corrected visual acuity, and, most importantly, helps prevent recurrent bleeding.
机译:目的:评估pars平板玻璃体切除术(PPV)的手术结果,硬化切开术部位纤维内膜的透热疗法以及周围视网膜向pars平面的辅助光凝治疗,作为继发于PPV的继发性玻璃体出血治疗增生性糖尿病性视网膜病变(PDR)。方法:西班牙巴塞罗那市Barraquer眼科中心三级护理中心。对PDR继发于PPV的巩膜切开部位新生血管形成的复发性玻璃体出血的14例连续20岁至47岁的连续患者的14眼前瞻性干预研究。所有患者均接受白内障或透明晶状体摘除,人工晶状体植入术加20规格PPV的玻璃体基底(包括巩膜切开术部位的嵌顿玻璃体),巩膜切开术部位纤维血管组织的内膜热疗和辅助的光凝术。术前评估是通过对新血管化硬化切开术部位,术前和术后视敏度(最小分辨角的对数)以及术后再出血率进行高分辨率的前兆20 MHz超声检查。结果:PDR初始PPV后8±4个月出现了玻璃体出血。十名(71%)患者的单个血管切开术部位发生了单独的血管形成,四名患者(29%)的2个动脉硬化切开术部位进行了血管形成。 18个血管化位点中有9个(50%)对应于光纤硬膜切开术,7个(39%)对应于玻璃体切开术,2(11%)对应于输注切开术。所有的新血管硬化术均在前段呈现前哨血管。随访23±10个月,无患者出现术后复发性玻璃体出血。从最初的2.23(标准偏差±1.13)到最终的0.23(标准偏差±0.09),所有患者的视力都得到了改善。结论:根据我们的研究,治疗PPV继发于PDR的复发性玻璃体出血的首选技术是硬化切开术部位纤维血管化的内透热疗法,以及周围视网膜至平面的辅助光凝。该技术可治疗问题的病因,改善最终的最佳矫正视力,最重要的是,有助于防止再次出血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号